RBC
GILD icon

Ronald Blue & Co’s Gilead Sciences GILD Stock Holding History

Ronald Blue & Co’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-2,763
Closed -$230K – 230
2016
Q2 		$230K Sell
2,763
-664
-19% -$58.9K 0.01% 176
2016
Q1 		$314K Buy
3,427
+1,079
+46% +$97.3K 0.02% 135
2015
Q4 		$238K Sell
2,348
-4,548
-66% -$473K 0.01% 154
2015
Q3 		$677K Sell
6,896
-2,137
-24% -$237K 0.04% 104
2015
Q2 		$1.06M Buy
9,033
+1,000
+12% +$109K 0.05% 80
2015
Q1 		$788K Sell
8,033
-1,161
-13% -$118K 0.04% 112
2014
Q4 		$867K Sell
9,194
-1,684
-15% -$174K 0.04% 100
2014
Q3 		$1.16M Buy
10,878
+559
+5% +$54.7K 0.08% 63
2014
Q2 		$855K Sell
10,319
-14
-0.1% -$1.09K 0.05% 95
2014
Q1 		$732K Buy
10,333
+2,032
+24% +$159K 0.05% 104
2013
Q4 		$623K Buy
8,301
+689
+9% +$48K 0.05% 115
2013
Q3 		$478K Buy
+7,612
New +$455K 0.04% 131

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ronald Blue & Co's GILD Position: Q3 2016 in Review

Ronald Blue & Co sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 2,763 shares — an estimated $230K sold.

Ronald Blue & Co first reported a position in GILD in Q3 2013 and held it in 12 quarters. The position peaked at $1.16M in Q3 2014. 1,557 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

  • Ronald Blue & Co reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
  • Ronald Blue & Co sold 2,763 Gilead Sciences shares in Q3 2016, an estimated $230K.
  • Ronald Blue & Co first reported a position in Gilead Sciences in Q3 2013 and held it in 12 quarters.
  • Ronald Blue & Co's Gilead Sciences position peaked at $1.16M in Q3 2014.
  • 1,557 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Ronald Blue & Co's 13F filing for Q3 2016, filed 17 Oct 2016.